Nanjing Leads Biolabs Co., Ltd. (9887) Announces Book Closure for Extraordinary General Meeting

Bulletin Express11-27

Nanjing Leads Biolabs Co., Ltd. (stock code: 9887) has scheduled an extraordinary general meeting (EGM) on Wednesday, December 17, 2025. According to the announcement, the register of members of H shares will be closed from Friday, December 12, 2025, to Wednesday, December 17, 2025 (inclusive), and no transfers of H shares will be processed during this period. Holders of H shares who intend to attend and vote at the EGM are required to submit transfer documents to the Company’s H share registrar in Hong Kong no later than 4:30 p.m. on Thursday, December 11, 2025. Those whose names appear on the register of members as of December 17, 2025, will be eligible to attend and vote.

A circular and notice of the EGM will be published in due course. As of November 27, 2025, the board of directors of Nanjing Leads Biolabs Co., Ltd. comprises executive directors Dr. Kang Xiaoqiang (Chairman), Dr. Lai Shoupeng, and Mr. Zuo Honggang; non-executive directors Mr. Zhang Yincheng, Dr. Chen Renhai, and Dr. Ni Jia; and independent non-executive directors Dr. Zhang Hongbing, Mr. Du Yilong, and Ms. Du Jiliu.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1188323561?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-27 19:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188323561","market":"us","top_or_hot":-1,"title":"Nanjing Leads Biolabs Co., Ltd. (9887) Announces Book Closure for Extraordinary General Meeting","media":"Bulletin Express","content":"<p>Nanjing Leads Biolabs Co., Ltd. (stock code: 9887) has scheduled an extraordinary general meeting (EGM) on Wednesday, December 17, 2025. According to the announcement, the register of members of H shares will be closed from Friday, December 12, 2025, to Wednesday, December 17, 2025 (inclusive), and no transfers of H shares will be processed during this period. Holders of H shares who intend to attend and vote at the EGM are required to submit transfer documents to the Company’s H share registrar in Hong Kong no later than 4:30 p.m. on Thursday, December 11, 2025. Those whose names appear on the register of members as of December 17, 2025, will be eligible to attend and vote.</p>\n<p>A circular and notice of the EGM will be published in due course. As of November 27, 2025, the board of directors of Nanjing Leads Biolabs Co., Ltd. comprises executive directors Dr. Kang Xiaoqiang (Chairman), Dr. Lai Shoupeng, and Mr. Zuo Honggang; non-executive directors Mr. Zhang Yincheng, Dr. Chen Renhai, and Dr. Ni Jia; and independent non-executive directors Dr. Zhang Hongbing, Mr. Du Yilong, and Ms. Du Jiliu.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nanjing Leads Biolabs Co., Ltd. (9887) Announces Book Closure for Extraordinary General Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNanjing Leads Biolabs Co., Ltd. (9887) Announces Book Closure for Extraordinary General Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-27 19:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nanjing Leads Biolabs Co., Ltd. (stock code: 9887) has scheduled an extraordinary general meeting (EGM) on Wednesday, December 17, 2025. According to the announcement, the register of members of H shares will be closed from Friday, December 12, 2025, to Wednesday, December 17, 2025 (inclusive), and no transfers of H shares will be processed during this period. Holders of H shares who intend to attend and vote at the EGM are required to submit transfer documents to the Company’s H share registrar in Hong Kong no later than 4:30 p.m. on Thursday, December 11, 2025. Those whose names appear on the register of members as of December 17, 2025, will be eligible to attend and vote.</p>\n<p>A circular and notice of the EGM will be published in due course. As of November 27, 2025, the board of directors of Nanjing Leads Biolabs Co., Ltd. comprises executive directors Dr. Kang Xiaoqiang (Chairman), Dr. Lai Shoupeng, and Mr. Zuo Honggang; non-executive directors Mr. Zhang Yincheng, Dr. Chen Renhai, and Dr. Ni Jia; and independent non-executive directors Dr. Zhang Hongbing, Mr. Du Yilong, and Ms. Du Jiliu.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09887","symbol_name":"维立志博-B","start_time":0,"source_url":"","article_id":"1188323561","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188323561","pubTimestamp":1764241786,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Nanjing Leads Biolabs Co., Ltd. (stock code: 9887) has scheduled an extraordinary general meeting (EGM) on Wednesday, December 17, 2025. According to the announcement, the register of members of H...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09887":"维立志博-B"},"translate_title":"南京立德生物实验室股份有限公司(9887)宣布股东特别大会暂停办理过户登记手续","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09887":1},"content_text":"Nanjing Leads Biolabs Co., Ltd. (stock code: 9887) has scheduled an extraordinary general meeting (EGM) on Wednesday, December 17, 2025. According to the announcement, the register of members of H shares will be closed from Friday, December 12, 2025, to Wednesday, December 17, 2025 (inclusive), and no transfers of H shares will be processed during this period. Holders of H shares who intend to attend and vote at the EGM are required to submit transfer documents to the Company’s H share registrar in Hong Kong no later than 4:30 p.m. on Thursday, December 11, 2025. Those whose names appear on the register of members as of December 17, 2025, will be eligible to attend and vote.\nA circular and notice of the EGM will be published in due course. As of November 27, 2025, the board of directors of Nanjing Leads Biolabs Co., Ltd. comprises executive directors Dr. Kang Xiaoqiang (Chairman), Dr. Lai Shoupeng, and Mr. Zuo Honggang; non-executive directors Mr. Zhang Yincheng, Dr. Chen Renhai, and Dr. Ni Jia; and independent non-executive directors Dr. Zhang Hongbing, Mr. Du Yilong, and Ms. Du Jiliu.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1188323561","isCrawlerRequest":true}